All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
During the Acute Leukemia Forum (ALF) 2021, the ALL Hub spoke to Stephan A. Grupp, Children’s Hospital of Philadelphia, Philadelphia, US. We asked, Why should CAR T-cell therapy be used earlier in ALL?
Why should CAR T-cell therapy be used earlier in ALL?
In this video, Grupp outlines what groups of patients with ALL could benefit from earlier treatment with CAR T-cell infusions.
EBMT and JACIE recommendations for the management of CAR T-cell therapy
Despite the targeted nature of CAR T-cell therapies, life-threatening toxicities are still associated with their use. The main CAR T-cell-associated complications have been...
What are the recent advances in immunotherapy for adult patients with ALL?
During the Acute Leukemia Forum (ALF) 2021, the ALL Hub spoke to Ibrahim T. Aldoss, City of Hope Comprehensive Cancer Center, Duarte, US. We asked, What are the recent...
Subscribe to get the best content related to ALL delivered to your inbox